Literature DB >> 27447981

Ophthalmic manifestations of tuberous sclerosis: a review.

Nickisa Hodgson1,2, Michael Kinori1, Michael H Goldbaum2, Shira L Robbins1.   

Abstract

Tuberous sclerosis or tuberous sclerosis complex (TSC), one of the phakomatoses, is characterized by hamartomas of the heart, kidney, brain, skin and eyes. Ophthalmologic examinations are required in all cases of TSC. Retinal hamartomas are the most common ocular finding in tuberous sclerosis. The majority of hamartomas are non-progressive; however, lesions with subretinal fluid and progression have been reported. This paper details the genetics, clinical features and ocular findings of TSC and reviews potential therapeutic options for ophthalmic manifestations.
© 2016 Royal Australian and New Zealand College of Ophthalmologists.

Entities:  

Keywords:  ophthalmic; review; tuberous sclerosis

Mesh：

Year:  2016        PMID： 27447981     DOI： 10.1111/ceo.12806

Source DB:  PubMed          Journal:  Clin Exp Ophthalmol        ISSN： 1442-6404            Impact factor:   4.207


  8 in total

1.  Analysis of Clinical Features and Next-Generation Sequencing of 12 Tuberous Sclerosis Families in China.

Authors:  Xu Wang; Wenda Wang; Yang Zhao; Zhan Wang; Yushi Zhang
Journal:  Front Med (Lausanne)       Date:  2022-05-27

2.  Case report: tuberous sclerosis and persistent hyperplastic primary vitreous.

Authors:  Hayley Wong; Sarah Bowie; Shona Handisides; Julia Escardó-Paton
Journal:  BMC Ophthalmol       Date:  2022-07-16       Impact factor: 2.086

3.  Mammalian target of rapamycin inhibitors for the treatment of astrocytic hamartoma in tuberous sclerosis complex (TSC).

Authors:  Ofri Vorobichik Berar; Michal Tzadok; Ofira Zloto; Iris Moroz; Idan Hecht; Anne Ampaire Musika; Omer Shlomovitz; Ido-Didi Fabian; Vicktoria Vishnevskia Dai
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-03-01       Impact factor: 3.535

4.  Tuberous sclerosis complex: a clinical case with multiple ophthalmological manifestations.

Authors:  Tiago Maio; José Lemos; Jorge Moreira; Filipa Sampaio
Journal:  BMJ Case Rep       Date:  2018-10-25

Review 5.  Role of mTORC1 Controlling Proteostasis after Brain Ischemia.

Authors:  Maria J Perez-Alvarez; Mario Villa Gonzalez; Irene Benito-Cuesta; Francisco G Wandosell
Journal:  Front Neurosci       Date:  2018-02-15       Impact factor: 4.677

6.  Subthreshold micropulse laser photocoagulation therapy in a case of bilateral retinal astrocytic hamartomas with tuberous sclerosis complex: A case report.

Authors:  Shenshen Yan; Yanyun Chen; Rui Chen; Bei Tian; Zheqing Li
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.817

7.  Neuro-ophthalmological manifestations of tuberous sclerosis: current perspectives.

Authors:  Michael J Wan; Ka Lo Chan; Benjamin G Jastrzembski; Asim Ali
Journal:  Eye Brain       Date:  2019-06-19

Review 8.  Utility of multimodal ocular imaging in tuberous sclerosis complex-Review of literature along with a case illustration.

Authors:  Ramesh Venkatesh; Nikitha G Reddy; Chaitra Jayadev; Abhishek Bhatt; Rohit Agrawal; Naresh K Yadav
Journal:  Indian J Ophthalmol       Date:  2022-07       Impact factor: 2.969
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.